scholarly journals The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease

2016 ◽  
Vol 17 (6) ◽  
pp. 383-395 ◽  
Author(s):  
Aaron R. Haeusler ◽  
Christopher J. Donnelly ◽  
Jeffrey D. Rothstein
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kadir. A. Ozcan ◽  
Layla T. Ghaffari ◽  
Aaron R. Haeusler

AbstractA nucleotide repeat expansion (NRE), (G4C2)n, located in a classically noncoding region of C9orf72 (C9), is the most common genetic mutation associated with ALS/FTD. There is increasing evidence that nucleic acid structures formed by the C9-NRE may both contribute to ALS/FTD, and serve as therapeutic targets, but there is limited characterization of these nucleic acid structures under physiologically and disease relevant conditions. Here we show in vitro that the C9-NRE DNA can form both parallel and antiparallel DNA G-quadruplex (GQ) topological structures and that the structural preference of these DNA GQs can be dependent on the molecular crowding conditions. Additionally, 5-methylcytosine DNA hypermethylation, which is observed in the C9-NRE locus in some patients, has minimal effects on GQ topological preferences. Finally, molecular dynamic simulations of methylated and nonmethylated GQ structures support in vitro data showing that DNA GQ structures formed by the C9-NRE DNA are stable, with structural fluctuations limited to the cytosine-containing loop regions. These findings provide new insight into the structural polymorphic preferences and stability of DNA GQs formed by the C9-NRE in both the methylated and nonmethylated states, as well as reveal important features to guide the development of upstream therapeutic approaches to potentially attenuate C9-NRE-linked diseases.


2011 ◽  
Vol 31 (05) ◽  
pp. 470-483 ◽  
Author(s):  
Fang He ◽  
Peter Todd

2020 ◽  
Vol 65 (5) ◽  
pp. 475-480 ◽  
Author(s):  
Haruko Nakamura ◽  
Hiroshi Doi ◽  
Satomi Mitsuhashi ◽  
Satoko Miyatake ◽  
Kazutaka Katoh ◽  
...  

Author(s):  
Indranil Malik ◽  
Chase P. Kelley ◽  
Eric T. Wang ◽  
Peter K. Todd

Neurology ◽  
1998 ◽  
Vol 51 (2) ◽  
pp. 548-553 ◽  
Author(s):  
J. Chapman ◽  
L. Cervenáková ◽  
R. B. Petersen ◽  
H.-S. Lee ◽  
J. Estupinan ◽  
...  

Background: The APOE genotype has been shown to influence the risk of developing sporadic and familial AD. This effect is isoform-dependent, the APOE ϵ4 allele increasing susceptibility and the APOE ϵ2 allele providing protection. Amyloid formation is an important part of the pathogenesis in AD as well as in spongiform encephalopathies; apoE deposition in amyloid plaques has been documented in both conditions.Methods: We examined the frequency of the APOE alleles in patients with various of transmissible spongiform encephalopathies, or prion diseases, including sporadic and iatrogenic Creutzfeldt-Jakob disease; familial Creutzfeldt-Jakob disease associated with PRNP 178N/129V and 200K/129M point mutations and a 24-nucleotide repeat expansion; fatal familial insomnia caused by the 178N/129M mutation; Gerstmann-Sträussler-Scheinker disease associated with 102L/129M mutation; and kuru.Results: None of the groups we studied had a significant excess of APOEϵ4 allele when compared with appropriate controls.Conclusions: Our results do not support the contention that the APOEϵ4 allele is a risk factor for developing Creutzfeldt-Jakob disease or related disorders.


Sign in / Sign up

Export Citation Format

Share Document